drugset

drugset / Trial / NCT00548353

A Study of Gastric Delay in Migraine Patients (3207-003)

NCT00548353 ↗

Phase 1 Completed 22 enrolled Merck Sharp & Dohme LLC

RandomizedParallel-groupDouble-blindTreatment

Summary

A study to assess safety and PK of an investigational drug in migraine patients during and between migraine attacks.

Timeline

Start: 2007-08
Primary completion: 2008-04
Completion: 2010-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	MK3207	Small molecule	100 mg	Oral

Indications